Navigation Links
OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
Date:7/7/2009

REDWOOD CITY, Calif., July 7 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel antibody therapeutics that target cancer stem cells, today announced the appointment of Sunil Patel to the position of Senior Vice President, Corporate Development. In this new position, Mr. Patel will have primary responsibility for corporate business development activities, reporting directly to Paul Hastings, OncoMed's President and Chief Executive Officer.

"We are pleased to welcome Sunil to the OncoMed management team. His track record in strategic deal making, particularly in the field of oncology drug discovery and development, make him a great addition," said Mr. Hastings. "Sunil's wealth of corporate development expertise will be an important asset for OncoMed as we discover novel anti-cancer stem cell therapeutics and advance our product candidates into clinical development."

Mr. Patel brings more than 15 years of biopharmaceuticals industry experience to his new role at OncoMed. He joins OncoMed from BiPar Sciences where as Vice President, Corporate Development and Marketing he led the sale of that company to Sanofi-Aventis in April of this year. Previously, he held senior corporate development, marketing, and strategy positions with Allos Therapeutics, Connetics Corporation, Abgenix and Gilead Sciences. Mr. Patel also served as a consultant with McKinsey & Company. Earlier in his career, he was a researcher at ZymoGenetics and ProCyte. Mr. Patel received his undergraduate degree in Chemistry at the University of California, Berkeley, and his master's degree in Molecular Bioengineering/Biotechnology at the University of Washington.

About OncoMed Pharmaceuticals

OncoMed Pharmaceuticals is a clinical-stage company that discovers and develops novel therapeutics targeting cancer stem cells, the cells believed to be capable of driving tumo
'/>"/>

SOURCE OncoMed Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. OncoMed Pharmaceuticals Completes Series B Financing
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... and SHENZHEN, China , July 31, ... the purchase of an Irys™System by ... BioNano,s platform to enable comprehensive exploration of human structural ... various organisms of interest, including those where no reference ... to develop new methods for multiplexing on the Irys ...
(Date:7/31/2014)... Chicago, IL (PRWEB) July 31, 2014 ... wave of automation across the U.S., increasing unemployment, ... middle class. It is a Catch 22—we ... internationally, but this means fewer jobs,” says economist ... the just-released Pollina Corporate Top 10 Pro-Business States ...
(Date:7/31/2014)... 2014 Sales Horizons, a leader in ... sales training course – Mastering the Complex Sale ... , Drawn from proven sales training programs used by ... Complex Sale online sales training course is available to ... face-to-face contact with customers, like technical support, engineers, clinical ...
(Date:7/30/2014)... 2014 A study presented at the ... efficacy of CSL Behring,s C1 Inhibitor (C1-INH) concentrate ... highly sensitized patients. C1-INH is a human protein ... The study shows that post-transplant treatment ... levels of complement components 3 and 4, suggesting ...
Breaking Biology Technology:BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3
... Jan. 14 Sigma-Aldrich Corporation,(Nasdaq: SIAL ), will ... Wednesday, February 11, 2009, at 11:00 a.m. Eastern Time,(10 a.m. ... being webcast by Thomson/CCBN and can be accessed at,Sigma-Aldrich,s Web ... The webcast is also being distributed through the Thomson ...
... Jan. 14 /PRNewswire-FirstCall/ - BioSyntech, Inc. (TSX: BSY), ... medicine, today announced that it will conclude enrolment ... its cartilage repair device, BST-CarGel(R). To date, the ... participating clinical sites will be permitted to enrol ...
... SAN FRANCISCO, Jan. 14 Inverseon, Inc. ( http://www.inverseon.com ... from the United States Patent Office covering its oral ... clinical asthma study was published in the January 10, ... would be the first patent for the utilization of ...
Cached Biology Technology:Sigma-Aldrich Corporation's 4th Quarter 2008 Earnings Conference Call 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 2BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 3BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009 4Inverseon's Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet 2
(Date:7/31/2014)... SHELTON, Conn. , July 31, 2014 /PRNewswire/ ... on the growing m-commerce market, reminds investors and ... generation smart wallet, Wocket™, that it will be on-air ... biometrically secure Wocket smart wallet will be featured ... consumer oriented television show that airs on the ...
(Date:7/31/2014)... new meta-analyses involving tree nuts (almonds, Brazil nuts, cashews, ... recently published in the online publications, British Medical ... ONE (ii). The BMJ Open article ... syndrome (MetS) criteria and showed that tree nut consumption ... blood glucose. The PLOS ONE article focused ...
(Date:7/30/2014)... reversible epigenetic processes to regulate its genes, and adapt ... picture of the genome regulation taking place in the ... Genome Biology and illustrates how the truffle deals ... The authors say this may shed light on how ... truffles (Tuber melanosporum), also known as Prigord truffles, have ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3New international tree nut council study looks at nuts, diabetes and metabolic syndrome 2How black truffles deal with the jumpers in their genome 2
... 2010 The television news and entertainment media are ... and helpful information about health and weight to Americans, ... Pace University in New York City. The National ... Prevent (STOP) Obesity Alliance organized the program, called "Weighty ...
... 2010) The goal of tissue engineering is to ... then transplant them into patients, where they are fully integrated. ... high-throughput imaging systems that allow researchers to directly monitor transplanted ... the culturing and implantation techniques, as well as the design ...
... Los Angeles, CA (1 April 2010)Two conservationists who have ... from the brink of extinction and ensure their habitat ... Tyler Prize for Environmental Achievement, one of the world,s ... inception in 1973, the Tyler Prize continues to be ...
Cached Biology News:Eating disorders, obesity and communications experts tackle 'weighty matters' 2Tissue engineering, imaging neuronal circuits featured in Cold Spring Harbor Protocols 2Leading conservation scientists awarded prestigious 2010 Tyler Environmental Prize 2Leading conservation scientists awarded prestigious 2010 Tyler Environmental Prize 3
...
Multidrop DW is a high-speed automated dispenser for Deep Well plates, 1.1 ml test tubes and 96-well plates. Designed for accuracy and precision, the Multidrop DW dispenses up to eight different reag...
... Rotor for use in the ... and Centra-MP4/MP4R. Perfect for ... and other difficult to separate ... containment. Complete with rotor and ...
... 45° Fixed Angle rotor for ... CL2, Centra CL3/CL3R, HN-SII or ... style rotor accepts 15 mL ... disposable conical tubes as well ...
Biology Products: